Cardiogen
Cardiogen is a synthetic short peptide bioregulator most commonly described as the tetrapeptide Ala-Glu-Asp-Arg (AEDR), studied in preclinical research for its potential role in cardiovascular cellular regulation. Research within the Khavinson bioregulator framework has explored its effects on cardiac tissue models, gene expression, and molecular pathways associated with myocardial function.
Cardiogen
Sale!6%
Cardiogen is a synthetic short peptide bioregulator most commonly described as the tetrapeptide Ala-Glu-Asp-Arg (AEDR), studied in preclinical research for its potential role in cardiovascular cellular regulation. Research within the Khavinson bioregulator framework has explored its effects on cardiac tissue models, gene expression, and molecular pathways associated with myocardial function.
$179.00
Buy more, save more!
-
Save 1%
Buy 3, get $2.50 off each
$179.00Per item: $176.50Total price: $529.50 -
Save 2%
Buy 5, get $3.75 off each
$179.00Per item: $175.25Total price: $876.25 -
Save 4%
Buy 10, get $7.50 off each
$179.00Per item: $171.50Total price: $1,715.00
$190.00$179.00
99+% PURITY
All peptides are third-party lab tested.
SECURE PAYMENT
Your payments are secure with our private security network.
FREE SHIPPING
for orders over $250
Description
Additional information
Reviews (0)
Cardiogen belongs to a class of short-chain synthetic peptides described as a bioregulator research framework developed to investigate tissue-specific regulatory processes at the cellular and genetic levels. Experimental studies have examined its interaction with cardiac cell populations and its potential influence on transcriptional activity associated with cardiovascular tissue maintenance, primarily in in vitro and animal models.
Current research continues to evaluate Cardiogen’s molecular stability, tissue-selective bioregulatory properties, and potential role in peptide-driven cellular communication, mainly within preclinical research programs rather than ongoing widely distributed international clinical research initiatives. Ongoing studies focus on understanding its mechanisms of action, transcriptional regulation behaviour, and broader applications in cardiovascular and molecular biology research in experimental model systems rather than established clinical pathways.
| Strength Variation |
|---|
There are no reviews yet.